Montelukast for bronchiolitis obliterans syndrome after lung transplantation: A randomized controlled trial

Bronchiolitis obliterans syndrome (BOS) remains the major problem which precludes long-term survival after lung transplantation. Previously, an open label pilot study from our group demonstrated a possible beneficial effect of montelukast in progressive BOS patients with low airway neutrophilia (<...

Descripción completa

Detalles Bibliográficos
Autores principales: Ruttens, David, Verleden, Stijn E., Demeyer, Heleen, Van Raemdonck, Dirk E., Yserbyt, Jonas, Dupont, Lieven J., Vanaudenaerde, Bart M., Vos, Robin, Verleden, Geert M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5889063/
https://www.ncbi.nlm.nih.gov/pubmed/29624575
http://dx.doi.org/10.1371/journal.pone.0193564

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5889063/
https://www.ncbi.nlm.nih.gov/pubmed/29624575
http://dx.doi.org/10.1371/journal.pone.0193564

Ejemplares similares